Professor Beth Fylan

Senior Lecturer in Patient Safety and Assistant Director, NIHR Yorkshire and Humber Patient Safety Research Collaboration

X: @bethfylan

Beth is Assistant Director for the Yorkshire and Humber Patient Safety Research Collaboration. She also has a dual role at the University of Bradford School of Pharmacy and Medical Sciences programme managing a National Institute of Health Research (NIHR) programme exploring and improving medicines management at transitions of care for people with heart failure (ISCOMAT).

Beth is an experienced health and social researcher and has worked extensively in the UK on research projects for national and local government, NHS organisations, charities, and the private sector. Her research has included national evaluations of health-related policy, for example she led the qualitative evaluation with GPs of the statement of fitness for work for the Department for Work and Pensions.

In Yorkshire and the Humber, Beth has led evaluations of services for bereaved families, those delivering outdoor activities for young people and those aiming to reduce recidivism. She has conducted research to redesign health services for patient benefit, and recently has co-facilitated a series of consultation events to understand and improve experiences of about breast diagnostic services. Beth has also designed and delivered training in research methods for clients such as Warwickshire County Council and the East of England and taught intervention development techniques, for example to university students on an EU programme aiming to make the transport environment in their local communities safer.

Beth has an MSc in Social Research Methods and Statistics at the University of Manchester and a PhD in which she explored the medicines-related professional and informal social networks of cardiology patients after they were discharged from hospital. Beth conducts qualitative, quantitative and mixed methods research.

Research interests
Beth’s research interests focus on the quality and safety of healthcare and how care can be improved. She has a particular interest in safety at care transitions, for example when people move between healthcare settings and providers.

Recent Publications

Powell, C., Fylan, B., Lord, K., Bell, F. Breen, L.  A qualitative analysis of stressors affecting 999 ambulance call handlers’ mental health and well-being (2022) Journal International Journal Of Emergency Services.

Powell, C., Tomlinson J., Quinn C., Fylan B., Interventions for self-management of medicines for community dwelling people with dementia, mild cognitive impairment and family carers: a systematic review 2022.Journal Age and Ageing. 

Peat G., Fylan B., Marques I., Raynor DK., Breen L., Olaniyan J., Alldred DP. Barriers and facilitators of successful deprescribing as described by older patients living with frailty, their informal carers and clinicians: a qualitative interview study 2022. 

Powell C., Ismail H., Davis M., Taylor A., Breen L; Fylan B; Alderson SL., Gale CP., Kellar I., Silcock J., Alldred DP. Experiences of patients with heart failure with medicines at transition intervention: Findings from the process evaluation of the Improving the Safety and Continuity of Medicines management at Transitions of care (ISCOMAT) programme 2022. Journal Health Expectations. 

Moreau LA., Holloway I., Fylan B., Hartley S., Cundill B., Fergusson A., Alderson S., Alldred DP., Bojke C., Breen L., Ismail H., Gardner P., Mason E., Powell C., Silcock J., Taylor A., Farrin A., Gale C. On behalf of the ISCOMAT Programme Management Team. Using routine healthcare data to evaluate the impact of the Medicines at Transitions Intervention (MaTI) on clinical outcomes of patients hospitalised with heart failure: protocol for the Improving the Safety and Continuity Of Medicines management at Transitions of care (ISCOMAT) cluster randomised controlled trial with embedded process evaluation, health economics evaluation and internal pilot 2022. Journal BMJ Open.

Peat G., Olaniyan J.,  Fylan B., Breen L., Grindey C., Hague I., Alldred DP. (2022) Mapping the resilience performance of community pharmacy to maintain patient safety during the Covid-19 pandemic. Journal Research In Social & Administrative Pharmacy : Rsap.  Science Direct. 

Jameson, A., Fylan, B., Bristow, G., Sagoo, G., Dalton, C., Cardno, A., Sohal, J. and McLean, S., 2021. What Are the Barriers and Enablers to the Implementation of Pharmacogenetic Testing in Mental Health Care Settings?. Frontiers in Genetics, 12. 

David, V., Fylan, B., Bryant, E., Smith, H., Sagoo, G. and Rattray, M., 2021. An Analysis of Pharmacogenomic-Guided Pathways and Their Effect on Medication Changes and Hospital Admissions: A Systematic Review and Meta-Analysis. Frontiers in Genetics, 12.

Fylan, B., Ismail, H., Hartley, S. et al. 2021.  A non-randomised feasibility study of an intervention to optimise medicines at transitions of care for patients with heart failure. Pilot Feasibility Stud 7, 85 2021.

Fylan, B., Tomlinson, J., Raynor, D. and Silcock, J., 2021. Using experience-based co-design with patients, carers and healthcare professionals to develop theory-based interventions for safer medicines use. Research in Social and Administrative Pharmacy, 17(12), pp.2127-2135. 

Powell, C., Ismail, H., Cleverley, R., Taylor, A., Breen, L., Fylan, B., Alderson, S. and Alldred, D., 2021. Patients as qualitative data analysts: Developing a method for a process evaluation of the ‘Improving the Safety and Continuity of Medicines management at care Transitions’ (ISCOMAT) cluster randomised control trial. Health Expectations, 24(4), pp.1254-1262. 10.1111/hex.13257

Medlinskiene, K., Richardson, S., Fylan, B., Stirling, K., Rattray, M. and Petty, D., 2021. Patient Perspectives on Factors Affecting Direct Oral Anticoagulant Use for Stroke Prevention in Atrial Fibrillation. Patient Preference and Adherence, Volume 15, pp.953-966.

Fylan, F. and Fylan, B., 2021. Co-creating social licence for sharing health and care data. International Journal of Medical Informatics, 149, p.104439. 10.1016/j.ijmedinf.2021.104439

Tomlinson, J., Marques, I., Silcock, J., Fylan, B. and Dyson, J., 2021. Supporting medicines management for older people at care transitions – a theory-based analysis of a systematic review of 24 interventions. BMC Health Services Research, 21(1).

Raynor, D.K., Ismail, H., Blenkinsopp, A., Fylan, B., Armitage, G. and Silcock, J. 2020. Experience‐based co‐design—Adapting the method for a researcher‐initiated study in a multi‐site setting. Health Expectations. https://doi.og/10.1111/hex.13028

Powell C, Breen L, Fylan B, et al Improving the Safety and Continuity Of Medicines management at Transitions of care (ISCOMAT): protocol for a process evaluation of a cluster randomised control trial. BMJ Open 2020;10:e040493.

Tomlinson, J., Cheong, V., Fylan, B., Silcock, J., Smith, H., Karban, K. and Blenkinsopp, A., 2020. Successful care transitions for older people: a systematic review and meta-analysis of the effects of interventions that support medication continuity. Age and Ageing, 49(4), pp.558-569.

Tomlinson, J., Silcock, J., Smith, H., Karban, K. and Fylan, B., 2020. Post‐discharge medicines management: the experiences, perceptions and roles of older people and their family carers. Health Expectations, 23(6), pp.1603-1613.

Fylan, B., Tranmer, M., Armitage, G. and Blenkinsopp, A., 2019. Cardiology patients’ medicines management networks after hospital discharge: A mixed methods analysis of a complex adaptive system. Research in Social and Administrative Pharmacy, 15(5), pp.505-513. 

Fylan, B., Marques, I., Ismail, H., Breen, L., Gardner, P., Armitage, G. and Blenkinsopp, A., 2019. Gaps, traps, bridges and props: a mixed-methods study of resilience in the medicines management system for patients with heart failure at hospital discharge. BMJ Open, 9(2), p.e023440.

Fylan, F., Caveney, L., Cartwright, A. and Fylan, B., 2018. Making it work for me: beliefs about making a personal health record relevant and useable. BMC Health Services Research, 18(1).

Fylan B, Armitage G, Naylor D, Blenkinsopp A. A qualitative study of patient involvement in medicines management after hospital discharge: an under-recognised source of systems resilience. BMJ Quality & Safety. 2017

Fylan Gwynn B, Blenkinsopp A, Armitage, G, Naylor, D. (2016) Discharged patients’ medicines management resilience strategies. Int J Pharm Pract. 24 (Suppl. 1), pp. 4–29

Fylan Gwynn, B., Blenkinsopp, A., Armitage, G., Naylor, D. (2014) Missed opportunities: the role of community pharmacy after discharge from cardiology wards. Int J Pharm Pract, 22 (S2), p.7-8

Fylan Gwynn, B, Blenkisnopp, A, Armitage, G., Naylor, D. (2013) “You have to be dying before you actually see a doctor…” Patients’ medicines safety networks at transfer of care. Conference presentation: EUSN European Conference on Social Networks 03/07. Universitat Autònoma de Barcelona

Fylan F, Fylan Gwynn B, Caveney L. (2013) Developing an interview topic guide for use in the pilot work capability assessment. DWP Research Report

Fylan F, Fylan Gwynn B, Caveney L. (2012) GPs’ perceptions of potential services to help employees on sick leave to return to work. DWP Research Report 820

Fylan, B., Fylan F., Caveney, L.  (2011). Evaluation of the Statement of Fitness for Work: qualitative research with General Practitioners. DWP Research Report 780